BOCQUET MEDICAL DIVISION COMMERCIAL : revenue, balance sheet and financial ratios

BOCQUET MEDICAL DIVISION COMMERCIAL is a French company founded 33 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in DOUAI (59500), this company of category PME shows in 2019 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BOCQUET MEDICAL DIVISION COMMERCIAL (SIREN 390335693)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C 1 405 555 € N/C 1 175 458 €
Net income 189 378 € 207 792 € 213 689 € 235 976 € 192 514 € 163 416 € 198 473 € 196 689 € 125 843 €
EBITDA N/C N/C N/C N/C N/C N/C 286 805 € N/C 540 749 €
Net margin N/C N/C N/C N/C N/C N/C 14.1% N/C 10.7%

Revenue and income statement

In 2025, BOCQUET MEDICAL DIVISION COMMERCIAL generates positive net income of 189 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 126 k€ -> 189 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

189 378 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

15.19%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

64.889%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

43.6%

Solvency indicators evolution
BOCQUET MEDICAL DIVISION COMMERCIAL

Sector positioning

Debt ratio
15.19 2025
2023
2024
2025
Q1: 0.0
Med: 5.56
Q3: 35.42
Average

In 2025, the debt ratio of BOCQUET MEDICAL DIVISION ... (15.19) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
64.89% 2025
2023
2024
2025
Q1: 10.79%
Med: 38.87%
Q3: 69.64%
Good

In 2025, the financial autonomy of BOCQUET MEDICAL DIVISION ... (64.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 376.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

376.93

Liquidity indicators evolution
BOCQUET MEDICAL DIVISION COMMERCIAL

Sector positioning

Liquidity ratio
376.93 2025
2023
2024
2025
Q1: 149.75
Med: 276.24
Q3: 581.63
Good

In 2025, the liquidity ratio of BOCQUET MEDICAL DIVISION ... (376.93) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
BOCQUET MEDICAL DIVISION COMMERCIAL

Positioning of BOCQUET MEDICAL DIVISION COMMERCIAL in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Valuation estimate

Based on 98 transactions of similar company sales (all years), the value of BOCQUET MEDICAL DIVISION COMMERCIAL is estimated at 919 155 € (range 185 065€ - 1 546 147€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
98 tx
185k€ 919k€ 1546k€
919 155 € Range: 185 065€ - 1 546 147€
NAF 5 all-time

Valuation method used

Net Income Multiple
189 378 € × 4.9x = 919 156 €
Range: 185 065€ - 1 546 147€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare BOCQUET MEDICAL DIVISION COMMERCIAL with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about BOCQUET MEDICAL DIVISION COMMERCIAL

What is the revenue of BOCQUET MEDICAL DIVISION COMMERCIAL ?

The revenue of BOCQUET MEDICAL DIVISION COMMERCIAL in 2019 is 1.4 M€.

Is BOCQUET MEDICAL DIVISION COMMERCIAL profitable?

Yes, BOCQUET MEDICAL DIVISION COMMERCIAL generated a net profit of 189 k€ in 2025.

Where is the headquarters of BOCQUET MEDICAL DIVISION COMMERCIAL ?

The headquarters of BOCQUET MEDICAL DIVISION COMMERCIAL is located in DOUAI (59500), in the department Nord.

Where to find the tax return of BOCQUET MEDICAL DIVISION COMMERCIAL ?

The tax return of BOCQUET MEDICAL DIVISION COMMERCIAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BOCQUET MEDICAL DIVISION COMMERCIAL operate?

BOCQUET MEDICAL DIVISION COMMERCIAL operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.